2025 Guidelines for the Evaluation and Management of Adults With Congenital Heart Disease
December 19, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
N/A
Synonyms :
travoprost intraocular implant
Class :
Antiglaucoma, Prostaglandin agonists
Brand Name :
N/A
Synonyms :
travoprost intraocular implant
Class :
Antiglaucoma, Prostaglandin agonists
Dosage Forms & Strengths
N/A
Open Angle Or Secondary Glaucoma
Awaiting FDA clearance to lower patients' excessive intraocular pressure (IOP) in those suffering with ocular hypertension or open-angle glaucoma
Dose Adjustments
N/A
Dosage Forms & Strengths
N/A
Pending FDA approval
Actions and Spectrum:
Actions:
This drug, a synthetic prostaglandin F analogue, is prescribed to treat ocular hypertension or open angle glaucoma.
Spectrum:
N/A
N/A
Black Box Warning:
N/A
N/A
Pregnancy consideration:
No data is available regarding the administration of the drug during pregnancy.
Breastfeeding warnings:
No data is available regarding the excretion of drug in breast milk.
Pregnancy category:
Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: No data is available for the drug under this category.
Pharmacology:
Prostaglandin F2-alpha analog: increases aqueous humor outflow through the trabecular meshwork, lowering intraocular pressure. Pharmacodynamics: N/A
Pharmacokinetics: N/A
Administration:
Pending FDA approval
Patient information leaflet
Generic Name: travoprost intraocular implant
Pronounced: trah-VOH-prost in-truh-AHK-yuh-ler im-plant
Why do we use travoprost intraocular implant?
This drug, a synthetic prostaglandin F analogue, is prescribed to treat ocular hypertension or open angle glaucoma. By encouraging the eye’s natural fluids to flow out more readily, it reduces intraocular pressure.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
